Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Aridis Pharmaceuticals Q1 Earnings

Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
May 16, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Aridis Pharmaceuticals beat estimated earnings by 13.73%, reporting an EPS of $-0.44 versus an estimate of $-0.51.

Revenue was up $1.19 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.51 which was followed by a 3.41% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aridis Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

JELD-WEN Holding’s Earnings Outlook

By Benzinga Insights
Today, 3:41 AM
JELD-WEN Holding (NYSE:JELD) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement. Analysts estimate that JELD-WEN Holding will likely report an Earnings Per Share (EPS) of $0.40

JELD